Wet Age Related Macular Degeneration and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Wet Age Related Macular Degeneration (AMD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Age
1.3 Global Wet Age Related Macular Degeneration (AMD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Wet Age Related Macular Degeneration (AMD) Overall Market Size
2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size: 2022 VS 2030
2.2 Global Wet Age Related Macular Degeneration (AMD) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Wet Age Related Macular Degeneration (AMD) Players in Global Market
3.2 Top Global Wet Age Related Macular Degeneration (AMD) Companies Ranked by Revenue
3.3 Global Wet Age Related Macular Degeneration (AMD) Revenue by Companies
3.4 Top 3 and Top 5 Wet Age Related Macular Degeneration (AMD) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Wet Age Related Macular Degeneration (AMD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Wet Age Related Macular Degeneration (AMD) Players in Global Market
3.6.1 List of Global Tier 1 Wet Age Related Macular Degeneration (AMD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Wet Age Related Macular Degeneration (AMD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Wet Age Related Macular Degeneration (AMD) Market Size Markets, 2022 & 2030
4.1.2 Wet Age-Related Macular Degeneration (Wet AMD)
4.1.3 Dry Age-Related Macular Degeneration (Dry AMD)
4.2 By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue & Forecasts
4.2.1 By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2023
4.2.2 By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2024-2030
4.2.3 By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
5 Sights by Age
5.1 Overview
5.1.1 By Age - Global Wet Age Related Macular Degeneration (AMD) Market Size, 2022 & 2030
5.1.2 Above 75 Years
5.1.3 Above 60 Years
5.1.4 Above 40 Years
5.2 By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue & Forecasts
5.2.1 By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2023
5.2.2 By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2024-2030
5.2.3 By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Wet Age Related Macular Degeneration (AMD) Market Size, 2022 & 2030
6.2 By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue & Forecasts
6.2.1 By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2023
6.2.2 By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue, 2024-2030
6.2.3 By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030
6.3.2 US Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.3.3 Canada Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.3.4 Mexico Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030
6.4.2 Germany Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.3 France Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.4 U.K. Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.5 Italy Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.6 Russia Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.7 Nordic Countries Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.4.8 Benelux Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030
6.5.2 China Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.5.3 Japan Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.5.4 South Korea Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.5.5 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.5.6 India Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030
6.6.2 Brazil Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.6.3 Argentina Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030
6.7.2 Turkey Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.7.3 Israel Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.7.4 Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
6.7.5 UAE Wet Age Related Macular Degeneration (AMD) Market Size, 2018-2030
7 Wet Age Related Macular Degeneration (AMD) Companies Profiles
7.1 Novartis International (Switzerland)
7.1.1 Novartis International (Switzerland) Company Summary
7.1.2 Novartis International (Switzerland) Business Overview
7.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.1.4 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.1.5 Novartis International (Switzerland) Key News & Latest Developments
7.2 Bayer (Germany)
7.2.1 Bayer (Germany) Company Summary
7.2.2 Bayer (Germany) Business Overview
7.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.2.4 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.2.5 Bayer (Germany) Key News & Latest Developments
7.3 Acucela (US)
7.3.1 Acucela (US) Company Summary
7.3.2 Acucela (US) Business Overview
7.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.3.4 Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.3.5 Acucela (US) Key News & Latest Developments
7.4 Neurotech Pharmaceuticals (US)
7.4.1 Neurotech Pharmaceuticals (US) Company Summary
7.4.2 Neurotech Pharmaceuticals (US) Business Overview
7.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.4.4 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.4.5 Neurotech Pharmaceuticals (US) Key News & Latest Developments
7.5 Ophthotech (US)
7.5.1 Ophthotech (US) Company Summary
7.5.2 Ophthotech (US) Business Overview
7.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.5.4 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.5.5 Ophthotech (US) Key News & Latest Developments
7.6 GlaxoSmithKline (US)
7.6.1 GlaxoSmithKline (US) Company Summary
7.6.2 GlaxoSmithKline (US) Business Overview
7.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.6.4 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline (US) Key News & Latest Developments
7.7 Alimera Sciences (US)
7.7.1 Alimera Sciences (US) Company Summary
7.7.2 Alimera Sciences (US) Business Overview
7.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.7.4 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.7.5 Alimera Sciences (US) Key News & Latest Developments
7.8 StemCell (Canada)
7.8.1 StemCell (Canada) Company Summary
7.8.2 StemCell (Canada) Business Overview
7.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.8.4 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.8.5 StemCell (Canada) Key News & Latest Developments
7.9 F. Hoffmann-La Roche (Switzerland)
7.9.1 F. Hoffmann-La Roche (Switzerland) Company Summary
7.9.2 F. Hoffmann-La Roche (Switzerland) Business Overview
7.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.9.4 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.9.5 F. Hoffmann-La Roche (Switzerland) Key News & Latest Developments
7.10 Regeneron Pharmaceutical (US)
7.10.1 Regeneron Pharmaceutical (US) Company Summary
7.10.2 Regeneron Pharmaceutical (US) Business Overview
7.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.10.4 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.10.5 Regeneron Pharmaceutical (US) Key News & Latest Developments
7.11 Allergan (Ireland)
7.11.1 Allergan (Ireland) Company Summary
7.11.2 Allergan (Ireland) Business Overview
7.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.11.4 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.11.5 Allergan (Ireland) Key News & Latest Developments
7.12 Adverum Biotechnologies (US)
7.12.1 Adverum Biotechnologies (US) Company Summary
7.12.2 Adverum Biotechnologies (US) Business Overview
7.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.12.4 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.12.5 Adverum Biotechnologies (US) Key News & Latest Developments
7.13 Gilead Sciences (US)
7.13.1 Gilead Sciences (US) Company Summary
7.13.2 Gilead Sciences (US) Business Overview
7.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Major Product Offerings
7.13.4 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue in Global Market (2018-2023)
7.13.5 Gilead Sciences (US) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Wet Age Related Macular Degeneration (AMD) Market Opportunities & Trends in Global Market
Table 2. Wet Age Related Macular Degeneration (AMD) Market Drivers in Global Market
Table 3. Wet Age Related Macular Degeneration (AMD) Market Restraints in Global Market
Table 4. Key Players of Wet Age Related Macular Degeneration (AMD) in Global Market
Table 5. Top Wet Age Related Macular Degeneration (AMD) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Wet Age Related Macular Degeneration (AMD) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Wet Age Related Macular Degeneration (AMD) Product Type
Table 9. List of Global Tier 1 Wet Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Wet Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Wet Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Wet Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Age ? Global Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Age - Wet Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Age - Wet Age Related Macular Degeneration (AMD) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2024-2030
Table 30. Novartis International (Switzerland) Company Summary
Table 31. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 32. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis International (Switzerland) Key News & Latest Developments
Table 34. Bayer (Germany) Company Summary
Table 35. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 36. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer (Germany) Key News & Latest Developments
Table 38. Acucela (US) Company Summary
Table 39. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 40. Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 41. Acucela (US) Key News & Latest Developments
Table 42. Neurotech Pharmaceuticals (US) Company Summary
Table 43. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 44. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 45. Neurotech Pharmaceuticals (US) Key News & Latest Developments
Table 46. Ophthotech (US) Company Summary
Table 47. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 48. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 49. Ophthotech (US) Key News & Latest Developments
Table 50. GlaxoSmithKline (US) Company Summary
Table 51. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 52. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline (US) Key News & Latest Developments
Table 54. Alimera Sciences (US) Company Summary
Table 55. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 56. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 57. Alimera Sciences (US) Key News & Latest Developments
Table 58. StemCell (Canada) Company Summary
Table 59. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 60. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 61. StemCell (Canada) Key News & Latest Developments
Table 62. F. Hoffmann-La Roche (Switzerland) Company Summary
Table 63. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 64. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 65. F. Hoffmann-La Roche (Switzerland) Key News & Latest Developments
Table 66. Regeneron Pharmaceutical (US) Company Summary
Table 67. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 68. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 69. Regeneron Pharmaceutical (US) Key News & Latest Developments
Table 70. Allergan (Ireland) Company Summary
Table 71. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 72. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 73. Allergan (Ireland) Key News & Latest Developments
Table 74. Adverum Biotechnologies (US) Company Summary
Table 75. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 76. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 77. Adverum Biotechnologies (US) Key News & Latest Developments
Table 78. Gilead Sciences (US) Company Summary
Table 79. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Offerings
Table 80. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue (US$, Mn) & (2018-2023)
Table 81. Gilead Sciences (US) Key News & Latest Developments
List of Figures
Figure 1. Wet Age Related Macular Degeneration (AMD) Segment by Type in 2022
Figure 2. Wet Age Related Macular Degeneration (AMD) Segment by Age in 2022
Figure 3. Global Wet Age Related Macular Degeneration (AMD) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Wet Age Related Macular Degeneration (AMD) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Wet Age Related Macular Degeneration (AMD) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2022
Figure 8. By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 9. By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 12. By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Age - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 16. US Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 20. Germany Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 21. France Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 28. China Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 32. India Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 34. Brazil Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share, 2018-2030
Figure 37. Turkey Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Wet Age Related Macular Degeneration (AMD) Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
